Activity Description

The LGBTQ Equity in HIV Prevention and Treatment is a multi-module series of HealthHIV and the National Coalition for LGBTQ Health to strengthen workforce capacity to provide comprehensive care to LGBTQ persons. The National Education Center LGBTQ Health addresses strategies that reduce health disparities for LGBTQ populations. The Center hosts brief, educational modules each within its own topic-specific series. The series will include five 30-45 minute modules on equitable access, structural barriers to care, medical mistrust, and care coordination, with a focus on engaging gay/bisexual Black and Latino men, and transgender persons, addressing structural racism, and enhancing culturally competent and sensitive care.


Content will focus on overcoming systemic barriers that persist in health access, such as literacy and education gaps, language justice, systemic discrimination, and healthcare misinformation or distrust. By highlighting these barriers and emphasizing an equity focus, the series aims to improve access to HIV prevention and treatment options among LGBTQ persons —especially those who are historically and routinely affected by the syndemics of ongoing and emerging epidemics.


Target Audience

This activity is intended for: 

Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers

Educational Objectives

After completing this activity, the participant should be better able to:

  • Increase knowledge of how intersectionality of sexual orientation, gender identity, race/ethnicity and HIV status impacts stigma in healthcare.
  • Integrate culturally-sensitive strategies for engaging same- gender-loving Black and Latino men in HIV prevention and care.
  • Identify key considerations for providing HIV care to transgender women.
  • Implement individualized strategies to improve access to HIV prevention and treatment services among LGBTQ persons.
Program Agenda

Individualizing HIV Prevention and Treatment for LGBTQ Persons

Accessing HIV Prevention and Care Services Among LGBTQ Persons

Providing Optimal HIV Care to Transgender and Gender Non-Conforming Persons

Engaging Same-Gender-Loving Black and Latino Men in HIV Prevention and Care

Addressing the Care Needs of Older Gay and Bisexual Men

Accreditation, Credit, and Support

HealthHIV logo        Joint accreditation logo
                                                                                                                                  

In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • Media: Enduring Material 

  • Release date: June 16, 2025

  • Expiration date: June 16, 2026

  • Time to Complete: 30 to 45 minutes per module

All modules are certified and participants can earn up to 2.75 credits/contact hours (CME, MOC, AAPA, ANCC, CPE, ASWB, APA) for completion of all program components. (5 modules).

Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of up to 2.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
A blue and white sign Description automatically generated with low confidenceSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.75  MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).

Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for up to 2.75 AAPA Category 1 CME credit. Approval is valid until June 16, 2026.


PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded up to 2.75 contact hours.

Continuing Pharmacy Education

HealthHIV designates this continuing education activity for up to 2.75 contact hours (0. 275 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

Please check each individual module for the assigned UAN number. 

Social Worker Continuing Education

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program.  Regulatory boards have the final authority on courses accepted for continuing education credit.

Social workers completing this course receive up to 2.75 general continuing education.


Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive up to 2.75 Interprofessional Continuing Education (IPCE) credit for learning and change.


Support Statement

This program has been supported by an independent educational grant from Gilead Sciences inc.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.

Faculty Disclosure

Please check individual modules for faculty disclosure statements.

Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity. 

Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.


For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.


For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).


For Pharmacists, HealthHIV  will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.


About This Activity

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV. 


The materials presented here are used with the permission of the authors and/or other sources. 


If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.


If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.



Individualizing HIV Prevention and Treatment for LGBTQ Persons

The LGBTQ Equity in HIV Prevention and Treatment Series Module 1 of 5

Target Audience

This activity is intended for: 

Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe the range of current HIV prevention and treatment options.
  • Demonstrate approaches to assessing patient preferences and needs through sexual health history-taking.
  • Identify appropriate HIV interventions for patients of various ages and demographics, including youth.
  • Integrate STI prevention strategies, such as DoxyPEP, into HIV prevention planning based on exposure risk and clinical guidance.
Accreditation, Credit, and Support

HealthHIV logo        Joint accreditation logo
                                                                                                                                  

In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


  • Media: Enduring Material 

  • Release date: June 9, 2025

  • Expiration date: June 9, 2026

  • Time to Complete: 45 minutes

Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
A blue and white sign Description automatically generated with low confidenceSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).

Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until June 9, 2026.   


PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.

Continuing Pharmacy Education

HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

Please see below for UAN number assigned to this activity: 

UAN JA4008396-0000-25-014-H02-P

Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.


Support Statement

This program has been supported by an independent educational grant from Gilead Sciences Inc.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.

Faculty Disclosure

Asia Sullivan, PA-C, MPH

Senior Physician Assistant Dr V Medical, Los Angeles

  • Asia Sullivan serves as a speaker on a Speakers Bureau for GlaxoSmithKline (GSK).
  • Asia Sullivan has received compensation for social media collaborations with the following commercial interests: Johnson & Johnson, GSK, LabCorp, GoodRx, and Novavax.

All relevant financial relationships have been mitigated in accordance with ACCME and Joint Accreditation standards for integrity and independence in accredited continuing education.

Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity. 

Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit.  Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.


For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.


For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).


For Pharmacists, HealthHIV  will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.


About This Activity

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV. 


The materials presented here are used with the permission of the authors and/or other sources.